Phreesia, Inc.
PHRNYSEHealthcare● Active
$9.34
$-0.20(-2.10%)
Market Cap$577323043
P/E Ratio—
52W High$32.76
52W Low$7.77
Phreesia, Inc. (PHR) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
PHR · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 27, 2026EPS Actual
$0.05
Est. $0.02 · +150.0%
Revenue
$0.13B
Est. $0.13B · +0.7%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 27, 2026
After Market Close
▲ Beat EPS🔥 11-Quarter EPS Beat Streak
PHR reports quarterly as a NYSE-listed Medical - Healthcare Information Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.09
Rev. $41.31B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.09
Rev. Est.$41.31B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Sep 3, 2026 | $0.10 | — | — | — | $0.13B | — |
| ▲ Q2 FY2026 | May 27, 2026 | $0.02 | $0.05 | +150.0% | $0.13B | $0.13B | +0.7% |
| ▲ Q1 FY2026 | Mar 30, 2026 | $0.07 | $0.12 | +82.6% | $0.13B | $0.13B | +0.3% |
| ▲ Q4 FY2025 | Dec 8, 2025 | -$0.00 | $0.10 | +27877.8% | $0.12B | $0.12B | +0.3% |
| ▲ Q3 FY2025 | Sep 4, 2025 | -$0.07 | $0.01 | +114.3% | $0.12B | $0.12B | -2.4% |
| ▲ Q2 FY2025 | May 28, 2025 | -$0.13 | -$0.07 | +46.1% | $0.12B | $0.12B | -0.3% |
| ▲ Q1 FY2025 | Mar 12, 2025 | -$0.19 | -$0.11 | +42.1% | $0.11B | $0.11B | +0.7% |
| ▲ Q4 FY2024 | Dec 9, 2024 | -$0.27 | -$0.25 | +7.4% | $0.11B | $0.11B | +0.5% |
Q3 FY2026
Sep 3, 2026
EPS Actual
—
EPS Est.
$0.10
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 27, 2026Beat
EPS Actual
$0.05
EPS Est.
$0.02
EPS Surpr.
+150.0%
Revenue
$0.13B
Q1 FY2026
Mar 30, 2026Beat
EPS Actual
$0.12
EPS Est.
$0.07
EPS Surpr.
+82.6%
Revenue
$0.13B
Q4 FY2025
Dec 8, 2025Beat
EPS Actual
$0.10
EPS Est.
-$0.00
EPS Surpr.
+27877.8%
Revenue
$0.12B
Q3 FY2025
Sep 4, 2025Beat
EPS Actual
$0.01
EPS Est.
-$0.07
EPS Surpr.
+114.3%
Revenue
$0.12B
Q2 FY2025
May 28, 2025Beat
EPS Actual
-$0.07
EPS Est.
-$0.13
EPS Surpr.
+46.1%
Revenue
$0.12B
Q1 FY2025
Mar 12, 2025Beat
EPS Actual
-$0.11
EPS Est.
-$0.19
EPS Surpr.
+42.1%
Revenue
$0.11B
Q4 FY2024
Dec 9, 2024Beat
EPS Actual
-$0.25
EPS Est.
-$0.27
EPS Surpr.
+7.4%
Revenue
$0.11B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2029 | $0.00 | $0.00 | $0.00 | 2 |
| Q4 FY2028 | $0.00 | $0.00 | $0.00 | 4 |
| Q3 FY2028 | $0.00 | $0.00 | $0.00 | 4 |
| Q2 FY2028 | $0.00 | $0.00 | $0.00 | 4 |
| Q1 FY2028 | $0.16 | $0.17 | $0.17 | 4 |
| Q4 FY2027 | $0.18 | $0.18 | $0.19 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2029 | $0.1B | $0.1B | $0.1B | 6 |
| Q4 FY2028 | $0.1B | $0.1B | $0.1B | 9 |
| Q3 FY2028 | $0.1B | $0.1B | $0.1B | 9 |
| Q2 FY2028 | $0.1B | $0.1B | $0.1B | 9 |
| Q1 FY2028 | $0.1B | $0.1B | $0.1B | 9 |
| Q4 FY2027 | $0.1B | $0.1B | $0.1B | 6 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 27, 2026 | +150.0% | $8.95 | $9.13 | +2.01% |
| ▲ Q1 FY2026 | Mar 30, 2026 | +82.6% | $10.98 | $11.41 | +3.92% |
| ▲ Q4 FY2025 | Dec 8, 2025 | +27877.8% | $20.29 | $20.12 | -0.84% |
| ▲ Q3 FY2025 | Sep 4, 2025 | +114.3% | $30.44 | $31.21 | +2.53% |
| ▲ Q2 FY2025 | May 28, 2025 | +46.1% | $24.95 | $23.30 | -6.61% |
| ▲ Q1 FY2025 | Mar 12, 2025 | +42.1% | $23.23 | $23.80 | +2.45% |
| ▲ Q4 FY2024 | Dec 9, 2024 | +7.4% | $21.73 | $21.63 | -0.46% |
| ▲ Q3 FY2024 | Sep 4, 2024 | +16.2% | $23.80 | $24.17 | +1.55% |
Q2 FY2026+2.01%
Report Date
May 27, 2026
EPS Beat/Miss
+150.0%
Price Before
$8.95
Price After
$9.13
Q1 FY2026+3.92%
Report Date
Mar 30, 2026
EPS Beat/Miss
+82.6%
Price Before
$10.98
Price After
$11.41
Q4 FY2025-0.84%
Report Date
Dec 8, 2025
EPS Beat/Miss
+27877.8%
Price Before
$20.29
Price After
$20.12
Q3 FY2025+2.53%
Report Date
Sep 4, 2025
EPS Beat/Miss
+114.3%
Price Before
$30.44
Price After
$31.21
Q2 FY2025-6.61%
Report Date
May 28, 2025
EPS Beat/Miss
+46.1%
Price Before
$24.95
Price After
$23.30
Q1 FY2025+2.45%
Report Date
Mar 12, 2025
EPS Beat/Miss
+42.1%
Price Before
$23.23
Price After
$23.80
Q4 FY2024-0.46%
Report Date
Dec 9, 2024
EPS Beat/Miss
+7.4%
Price Before
$21.73
Price After
$21.63
Q3 FY2024+1.55%
Report Date
Sep 4, 2024
EPS Beat/Miss
+16.2%
Price Before
$23.80
Price After
$24.17
Avg Beat Reaction+0.57%
Beat Rate8 / 8 quarters
Largest Move-6.61% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: PHR ends December
Phreesia, Inc. (PHR) most recently reported earnings on May 27, 2026 for Q2 FY2026, posting EPS of $0.05 — beating the analyst consensus of $0.02 by +150.0%. PHR has beaten EPS estimates for 11 consecutive quarters. The next PHR earnings date is expected around September 1, 2026.
Each quarter, investors track PHR earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. PHR revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
PHR's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
PHR earnings · 5 questionsPhreesia, Inc.'s next earnings report is expected around September 1, 2026. PHR typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; PHR historically reports after market close (AMC).
PHR earnings datewhen is PHR earningsPHR next earnings datewhen does PHR report earningsPHR earnings calendar
▸ Source: FMP · Phreesia, Inc. SEC filings · US GAAP · Phreesia, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026